Running title: Optimal Dosing of rhEPO in TKA Patients
Zichuan Ding1, Mingcheng Yuan1, Qifeng Tao2, Duan Wang1, Haoyang Wang1,*, Zongke Zhou1,*
1 Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, P.R. China.
2 Department of Orthopedics, Panzhihua Municipal Central Hospital Panzhihua, Panzhihua, People’s Republic of China.
* Corresponding author: Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, P.R. China.
Zichuan Ding and Mingcheng Yuan contributed equally to this work.
Principal investigator statement: The authors confirm that the principal investigator for this paper is Zongke Zhou and that he had direct clinical responsibility for patients.
Key words: total knee arthroplasty, recombinant human erythropoietin, autologous blood donation, dosing schedule